Goldman Sachs initiated coverage of Alexandria Real Estate (ARE) with a Neutral rating and $60 price target The firm says the company’s “high-quality” assets are balanced by “systemic pressures” on the U.S. life science industry. Goldman’s lab space demand model indicates an “extended and gradual” life science recovery with net absorption only turning sustainably positive in 2027, the analyst tells investors in a research note. It cites an extended recovery timeline for Alexandria’s tenant demand and uncertainty around the life science ecosystem for the Neutral rating.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARE:
- Alexandria Real Estate price target raised to $61 from $60 at BofA
- Balanced Risk-Reward Amid Mixed Fundamentals and Uncertain Demand Supports Hold on Alexandria Real Estate Equities
- Alexandria Real Estate Maps a Difficult 2026 Trough
- Vanguard S&P 500 ETF (VOO) Daily Update, 1/28/2026
- SPY ETF Daily Update, 1/28/2026